Targeted Drug Delivery to Central Nervous System (CNS) for the Treatment of Neurodegenerative Disorders: Trends and Advances

Author(s): Kritika Goyal, Veena Koul, Yashveer Singh, Akshay Anand

Journal Name: Central Nervous System Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Central Nervous System Agents

Volume 14 , Issue 1 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The treatment of brain diseases has been a major challenge since a long time. Although there are several potent drugs, which are highly therapeutic yet their efficiency is marred due to the presence of the Blood Brain Barrier (BBB). The BBB, which is present at the capillary level regulates and monitors the entry of all small and large molecules entering into the brain. Although this barrier is of immense importance to the brain in terms of safety, it becomes a hindrance when it comes to therapy because the drug molecules are unable to reach the brain. Various biomaterial-based strategies are being developed to overcome the BBB and deliver the drug into the brain. These include polymeric nanoparticles, liposomes, solid-lipid nanoparticles (SLNPs), nanogels, implants, etc. This review provides an overview on CNS disorders, BBB, and various delivery strategies available for biologists engaged in translational neuroscience, to target CNS.

Keywords: Blood-brain barrier (BBB), CNS drug delivery, drug transport, targeting.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 20 November, 2014
Page: [43 - 59]
Pages: 17
DOI: 10.2174/1871524914666141030145948

Article Metrics

PDF: 147